New vectors and strategies for cardiovascular gene therapy.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current Gene Therapy

• Publication date

  2007-01-31

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.2174/156652307779940243PMID 17305525PMCID PMC2096717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro and in vivo analysis of expression cassettes designed for vascular gene transfer

  2008cited by this paper
• Utility of Vascular Endothelial Specific Peptides for Enhancement of Adeno-Associated Virus-Mediated Gene Transfer

  2008cited by this paper
• Stem Cell Therapy for Ischemic Heart Disease: Beginning or End of the Road?

  2006cited by this paper
• Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI

  2006cited by this paper
• Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice

  2006cited by this paper
• Beta-Adrenoceptor Blockade Markedly Attenuates Transgene Expression From Cytomegalovirus Promoters Within the Cardiovascular System

  2006influential reference
• Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial

  2006cited by this paper
• A Constitutively Active Hypoxia-Inducible Factor-1α/VP16 Hybrid Factor Activates Expression of the Human B-Type Natriuretic Peptide Gene

  2006cited by this paper
• Insertional Mutagenesis at Positions 520 and 584 of Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Generation of AAV2 Vectors with Eliminated Heparin- Binding Ability and Introduced Novel Tropism

  2006cited by this paper
• Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo

  2006cited by this paper
• Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery.

  2006cited by this paper
• Cardiomyocyte-Specific Overexpression of NO Synthase-3 Protects Against Myocardial Ischemia-Reperfusion Injury

  2006cited by this paper
• H11 Kinase Prevents Myocardial Infarction by Preemptive Preconditioning of the Heart

  2006cited by this paper
• Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.

  2006cited by this paper
• AAV Serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect

  2006cited by this paper
• Combination of In Vivo Angiopoietin-1 Gene Transfer and Autologous Bone Marrow Cell Implantation for Functional Therapeutic Angiogenesis

  2006influential reference
• Adeno-associated virus serotypes: vector toolkit for human gene therapy.

  2006influential reference
• Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain.

  2006cited by this paper
• Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation.

  2006cited by this paper
• Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells

  2006cited by this paper
• Impaired Angiogenesis in Glutathione Peroxidase-1–Deficient Mice Is Associated With Endothelial Progenitor Cell Dysfunction

  2006cited by this paper
• Potential Therapeutic Gene for the Treatment of Ischemic Disease: Ad2/Hypoxia-Inducible Factor-1α (HIF-1)/VP16 Enhances B-Type Natriuretic Peptide Gene Expression via a HIF-1-Responsive Element

  2006cited by this paper
• New strategies for cardiovascular gene therapy

  2006cited by this paper
• Treatment with Intramuscular Vascular Endothelial Growth Factor Gene Compared with Placebo for Patients with Diabetes Mellitus and Critical Limb Ischemia: A Double-Blind Randomized Trial

  2006influential reference
• AAV hybrid serotypes: improved vectors for gene delivery.

  2005cited by this paper
• Gene therapy: twenty-first century medicine.

  2005cited by this paper
• 12th Annual Congress of the European Society of Gene Therapy

  2005cited by this paper
• Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end?

  2005cited by this paper
• Gene therapy for severe combined immunodeficiency.

  2005cited by this paper
• Endothelial Progenitor Cell Dysfunction in Type 1 Diabetes: Another Consequence of Oxidative Stress?

  2005cited by this paper
• Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector.

  2005cited by this paper
• Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE)

  2005influential reference
• Ischaemic preconditioning protects against ischaemia/reperfusion injury: emerging concepts.

  2005cited by this paper
• Ischemic Preconditioning by Unstable Angina Reduces the Release of CK‐MB Following CABG and Stimulates Left Ventricular HSP‐72 Protein Expression

  2005influential reference
• Altering AAV tropism with mosaic viral capsids.

  2005cited by this paper
• Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors.

  2005cited by this paper
• Update on therapeutic neovascularization.

  2005cited by this paper
• As Gelsinger Case Ends, Gene Therapy Suffers Another Blow

  2005cited by this paper
• VEGF Links Hippocampal Activity with Neurogenesis, Learning, and Memory.

  2005cited by this paper
• Widespread and early myocardial gene expression by adeno-associated virus vector type 6 with a beta-actin hybrid promoter.

  2005cited by this paper
• VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B–PDGFRβ signaling

  2005influential reference
• Adeno-Associated Virus Types 5 and 6 Use Distinct Receptors for Cell Entry

  2005cited by this paper
• Harnessing HIV for therapy, basic research and biotechnology.

  2005cited by this paper
• Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation

  2005cited by this paper
• Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.

  2005cited by this paper
• Cell‐selective viral gene delivery vectors for the vasculature

  2005cited by this paper
• Efficient Transduction of Vascular Endothelial Cells with Recombinant Adeno-Associated Virus Serotype 1 and 5 Vectors

  2005cited by this paper
• Integration of adeno-associated virus (AAV) and recombinant AAV vectors.

  2004cited by this paper
• Cross-Dressing the Virion: the Transcapsidation of Adeno-Associated Virus Serotypes Functionally Defines Subgroups

  2004cited by this paper
• Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.

  2004cited by this paper
• Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity.

  2004cited by this paper
• Gene transfer into rabbit arteries with adeno‐associated virus and adenovirus vectors

  2004cited by this paper
• VEGF links hippocampal activity with neurogenesis, learning and memory

  2004cited by this paper
• Angiogenic effects of dual gene transfer of bFGF and PDGF-BB after myocardial infarction.

  2004influential reference
• Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies.

  2004cited by this paper
• Efficacy of gene therapy for SCID is being confirmed.

  2004cited by this paper
• Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival

  2004influential reference
• Targeted Gene Delivery to Vascular Tissue In Vivo by Tropism-Modified Adeno-Associated Virus Vectors

  2004cited by this paper
• Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial

  2004cited by this paper
• Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.

  2004influential reference
• Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

  2004cited by this paper
• Protection From Ischemic Heart Injury by a Vigilant Heme Oxygenase-1 Plasmid System

  2004cited by this paper
• Therapeutic angiogenesis using hepatocyte growth factor (HGF).

  2004cited by this paper
• Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.

  2004cited by this paper
• Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues

  2004cited by this paper
• Gene therapy clinical trials worldwide 1989–2004—an overview

  2004cited by this paper
• Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury.

  2004cited by this paper
• Enhanced Inhibition of Neointimal Hyperplasia by Genetically Engineered Endothelial Progenitor Cells

  2004cited by this paper
• Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress.

  2004cited by this paper
• Gene therapy for severe combined immunodeficiency

  2004cited by this paper
• Gene therapy for cardiovascular diseases.

  2004cited by this paper
• Augmentation of Therapeutic Angiogenesis Using Genetically Modified Human Endothelial Progenitor Cells with Altered Glycogen Synthase Kinase-3β Activity*

  2004cited by this paper
• Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.

  2004cited by this paper
• HIF-1: the knowns and unknowns of hypoxia sensing.

  2004cited by this paper
• Akt/Protein Kinase B and Endothelial Nitric Oxide Synthase Mediate Muscular Neovascularization Induced by Tissue Kallikrein Gene Transfer

  2004cited by this paper
• Human Endothelial Progenitor Cells Tolerate Oxidative Stress Due to Intrinsically High Expression of Manganese Superoxide Dismutase

  2004cited by this paper
• Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.

  2004cited by this paper
• VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

  2004cited by this paper
• Genetic redox preconditioning differentially modulates AP-1 and NF kappa B responses following cardiac ischemia/reperfusion injury and protects against necrosis and apoptosis.

  2003influential reference
• Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.

  2003cited by this paper
• Fibroblast growth factor‐4 induces vascular permeability, angiogenesis, and arteriogenesis in a rabbit hind limb ischemia model

  2003influential reference
• Infarct Remodeling After Intracoronary Progenitor Cell Treatment in Patients With Acute Myocardial Infarction (TOPCARE-AMI): Mechanistic Insights From Serial Contrast-Enhanced Magnetic Resonance Imaging

  2003cited by this paper
• Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

  2003cited by this paper
• Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors.

  2003cited by this paper
• Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors.

  2003cited by this paper
• The VIVA Trial Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis

  2003cited by this paper
• From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.

  2003cited by this paper
• VEGF-D Is the Strongest Angiogenic and Lymphangiogenic Effector Among VEGFs Delivered Into Skeletal Muscle via Adenoviruses

  2003influential reference
• Gene transfer as a tool to induce therapeutic vascular growth

  2003cited by this paper
• Generation and characterization of chimeric recombinant AAV vectors.

  2003cited by this paper
• AAV-based gene transfer.

  2003cited by this paper
• Lentivirus vector-mediated gene transfer to cardiomyocytes.

  2003cited by this paper
• Looking into the safety of AAV vectors

  2003cited by this paper
• Regulation of Angiogenesis by Glycogen Synthase Kinase-3β*

  2002cited by this paper
• Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy.

  2002cited by this paper
• Defining gene transfer before expecting gene therapy: putting the horse before the cart.

  2002cited by this paper
• Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo

  2002cited by this paper
• Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis.

  2002cited by this paper
• Endothelial Progenitor Cell Vascular Endothelial Growth Factor Gene Transfer for Vascular Regeneration

  2002cited by this paper
• Cellular glutathione peroxidase deficiency and endothelial dysfunction.

  2002influential reference

• Antheraea pernyi silk fibroin-coated adenovirus as a VEGF165-Ang-1 dual gene delivery vector

  2022cites this paper
• Application of new lysine-based peptide dendrimers D3K2 and D3G2 for gene delivery: Specific cytotoxicity to cancer cells and transfection in vitro.

  2019cites this paper
• Therapeutic angiogenesis: recent and future prospects of gene therapy in peripheral artery disease.

  2014cites this paper
• Nrf2 Regulates Angiogenesis: Effect on Endothelial Cells, Bone Marrow-Derived Proangiogenic Cells and Hind Limb Ischemia

  2014cites this paper
• 자연적으로 유발된 고혈압 백서에서 안지오텐신 전환효소를 억제하는 Small Hairpin RNA Effect of Small Hairpin RNA Molecules Targeting Angiotensin-converting Enzyme Gene in Spontaneously Hypertensive Rats

  2012cites this paper
• AAV-based shRNA silencing of NF-κB ameliorates muscle pathologies in mdx mice

  2012cites this paper
• Effect of Small Hairpin RNA Molecules Targeting Angiotensin-converting Enzyme Gene in Spontaneously Hypertensive Rats

  2012cites this paper
• Adenovirus-based gene therapy approaches for hemophilia B

  2012cites this paper
• [Progress in gene therapy].

  2011cites this paper
• Therapeutic potential of heme oxygenase-1 in cardiovascular disease

  2011cites this paper
• Gene Therapy and Muscles: The Use of Adeno-associated Virus—Where are We Today?

  2010cites this paper
• AAV-directed muscular dystrophy gene therapy

  2010cites this paper
• GPR30 Differentially Regulates Short Latency Responses of Luteinising Hormone and Prolactin Secretion to Oestradiol

  2009cites this paper
• Current Status of Therapeutic Angiogenesis with Protein, Gene and Cell Therapy

  2009cites this paper
• Human studies of angiogenic gene therapy.

  2009cites this paper
• A role for adeno-associated viral vectors in gene therapy

  2008cites this paper
• A review of current progress in gene and stem cell therapy for erectile dysfunction

  2008cites this paper
• Selection and characterization of targeted vector capsids from random adeno-associated virus type 2 (AAV-2) display peptide libraries

  2008cites this paper
• In vitro and in vivo analysis of expression cassettes designed for vascular gene transfer

  2008cites this paper
• Utility of Vascular Endothelial Specific Peptides for Enhancement of Adeno-Associated Virus-Mediated Gene Transfer

  2008cites this paper
• Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry Enhancing Hepatic Fatty Acid Oxidation as a Strategy for Reversing Metabolic Disorders Programmed by Maternal Undernutrition during Gestation Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry

  year unknowncites this paper